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Abstract  
 
Hypertension is the single most important modifiable risk factor for adult stroke. 
Stroke mortality has significantly decreased over the last five decades; this 
decline has been mainly associated to improved blood pressure (BP) control. 
Although much less prevalent than in adults, stroke is an increasingly recognized 
cause of morbidity and mortality in children. Although hypertension has not been 
strongly identified as a risk factor in childhood stroke yet, there is preliminary 
evidence that suggests that elevated BP may be associated with stroke in 
children.  
In this review, we summarized the literature that may link elevated BP to the 
development of childhood ischemic and hemorrhagic stroke. We suggest that 
elevated BP may be a significant risk factor that, alone or in combination with 
other multiple risk factors, leads to the development of stroke in childhood. We 
recommend that BP be measured and assessed carefully in every child 
presenting with acute stroke.  
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I. Introduction 
Hypertension is the single most important modifiable risk factor for stroke in 
adults.1 In the past five decades, stroke mortality has significantly decreased 
from the third leading cause of death in the 1960s to the fifth cause in 2013.2 This 
decline is mainly attributable to improved blood pressure (BP) control.3  
Although much less prevalent than in adults, stroke is still one of the top ten 
causes of childhood death.2 In children, multiple etiologies are associated with 
the development of stroke.4,5 Although hypertension has not been strongly 
identified as a risk factor in childhood stroke to date, there is preliminary 
evidence that suggests that elevated BP may also be associated with stroke in 
children.  
Hypertension has increased among children and adolescents in the last two 
decades, which parallels the current childhood obesity epidemics. The 
prevalence of hypertension is estimated to be three to four percent in children in 
general, but as high as ten percent in children with obesity. 6-9  Hypertensive 
children and adolescents develop subclinical target organ damage, such as left 
ventricular hypertrophy and carotid intimal thickness.10-13 In addition, 
hypertension may affect the child’s central nervous system, including retinal, 
cerebrovascular, and cognitive abnormalities.14-18 Thus, the possibility that 
elevated BP might contribute to stroke in children should not be underestimated.  
We performed literature searches on three databases: PubMed, Embase and 
Web of Science. Our searches combined the concepts of stroke, brain ischemia, 
brain hemorrhage, and hypertension with the AND operator. The PubMed search 
 4 
included Mesh terms and keywords. Our Embase search included Emtree terms 
and keywords. In addition, we included references from articles retrieved through 
these searches. 
 
II. Epidemiology 
Incidence of Childhood Stroke 
The incidence of childhood stroke has varied widely in the literature over the 
years,19-22 from 2.5/100,00019 to 13.5/100,00021 children per year. On average, 
the combined incidence rates for ischemic and hemorrhagic stroke is 
6.8/100,000.22 The relative proportion of stroke type has also varied broadly; the 
ischemic to hemorrhagic stroke ratio has changed overtime from 0.33 to 2.67.19-22 
Early studies reported a higher proportion of hemorrhagic stroke;19,20 more recent 
studies show higher rates of ischemic stroke.21,22  
As traditional cardiovascular risk factors (such as obesity and hypertension) are 
becoming more prevalent among children at younger ages,6,23 the incidence 
rates of childhood stroke may be rising as well.24 
 
Prevalence of Hospitalization for Stroke 
Hospitalization rates for ischemic stroke in children and young adults increased 
significantly from 1995 to 2008,25 from 3.1 to 4.7/10,000 hospitalizations (51%) in 
five to 14 year-old boys, from 10.3 to 15.0/10,000 hospitalizations (45.6%) in 15 
to 34 year- old males and from 3.5 to 4.3/10,000 hospitalizations (22.9%) in 15 to 
34 year-old females; rates were unchanged in girls five to 14.25  
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The prevalence of hospitalization due to hemorrhagic stroke increased from 1.6 
to 2.4/10,000 (50%; subarachnoid) and from 1.9 to 2.6/10,000 (36.8%; 
intracerebral) in boys and girls five to 14. In contrast, hospitalization rates for 
hemorrhagic stroke decreased in the 15 to 34 year-old group in general, mainly 
due to significantly lower rates in females (33% decreased for subarachnoid 
type).25   
Hospitalization rates may increase as awareness of childhood stroke increases 
or because fewer children die pre-hospitalization. The latter may be the case for 
hemorrhagic stroke, although there are few population-based data, which include 
an estimate of mortality outside hospital. 
 
III. Hypertension and Stroke: Definitions, Barriers and Limitations 
The standard definition of hypertension in children and adolescents is based on 
the normative distribution of blood pressure (BP) in healthy children; it is not 
based on clinical outcomes.26 Hypertension is defined as a systolic BP and/or a 
diastolic BP equal or greater than the 95th percentile on repeated 
measurements. When the BP falls between the 90th and 95th percentiles, it is 
called prehypertension.26   
Data on the impact of BP on stroke in children differ by the definition of high BP 
used.  Some studies describing the association between BP and stroke in 
children included only children with the standard definition of hypertension above 
while other studies included children with elevated BP on just a single occasion, 
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not on repeated measures over time.  For the purposes of this review, we have 
used the term “hypertension” for studies that included subjects who met the 
standard definition of hypertension and the term “elevated BP” for studies that 
also included subjects with high BP but did not necessarily have repeated 
measures over time.  
Newer techniques, such as 24-hour ambulatory BP monitoring, are now available 
to establish and confirm the diagnosis of hypertension.27,28 This procedure allows 
for a better assessment of BP changes, by providing measurements outside the 
office setting and by evaluating BP load (a measure of duration of BP elevation).  
Both hypertension and prehypertension are under-recognized in the pediatric 
population.29 BP is not measured in a significant proportion of ambulatory visits; 
hence, hypertension and prehypertension are likely to be undiagnosed in the 
pediatric stroke population, as well. Children may also have masked 
hypertension,30 defined as a normal BP in the office but elevated in the out-of-
office setting. Thus, in order to confirm masked hypertension, a 24-hour BP study 
would be necessary to confirm this diagnosis.31   
Children and adolescents with severe BP elevation are at increased risk of 
neurologic adverse outcomes, including hypertensive encephalopathy and 
cerebrovascular accidents.14,32 However, hypertension as a stroke risk factor, 
has been largely ignored in the pediatric literature.5  Various stroke symptoms 
were reported in single patients or small case series with conditions where 
elevated BP was clearly associated with, or was an important risk factor in 
underlying conditions.31,33-44 
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We have identified multiple barriers to recognize the contribution of elevated BP 
to the development of stroke in childhood. Case series and review articles on 
pediatric stroke often did not mention elevated BP as a potential risk factor45,46 
(except in sickle cell disease, where it is a risk factor for both ischemic and 
hemorrhagic stroke).47 Other stroke studies have not specified how the BP was 
obtained and interpreted or defined hypertension at much higher BP thresholds, 
underestimating its incidence.48-51 In addition, there is no consensus regarding 
the timing of BP assessment; studies have defined hypertension at different time 
periods (i.e., at presentation, discharge, or follow up visit).4,49 One study found 
that the BP was frequently abnormal, rarely measured and infrequently plotted on 
percentile charts.50 Another study noted that BP assessment was suboptimal 
because height was inconsistently documented (as normal BP in children varies 
with different heights).26 Other limitations included lack of controlled and serial 
measurements and under-reporting of specific risk factors.48,52 McKay et al. 
suggested that hypertension prevalence might have been underestimated on the 
International Pediatric Stroke Study database, because there was no 
predetermined field on data entry sheet for modifiable adult risk factors.48 
Finally, large databases utilize ICD-9 and 10 discharge codes to identify subjects 
with hypertension; these are indeed administrative codes and not medical 
diagnosis. It is uncertain whether coding was appropriate and relevant in all 
cases. 
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IV. Elevated BP and Ischemic Stroke  
Studies on pediatric ischemic stroke have increasingly identified a link with 
elevated BP (Table 1).4,5,25,32,48,49,53-59 The prevalence of hypertension in ischemic 
stroke has been reported to vary between 5-65%, depending on how 
hypertension was defined. Kirkham et al. analyzed risk factors for arterial 
ischemic stroke and found that ten percent (8/83) with a first ischemic stroke or 
transient ischemic attack (TIA) were hypertensive. As hypertension was the only 
obvious factor in some of these cases, the authors suggested that hypertension 
could have played an etiologic role.5  
George et al. reported an increase in the prevalence of classic cardiovascular 
risk factors among US adolescents and young adults hospitalized for ischemic 
stroke from 1995 to 2008.  Hypertension, as a coexisting risk factor for stroke, 
increased from 25.3 to 37.2 percent (p<0.001) in 15 to 34 year-old males and 
from 19.2 to 32.2 percent (p<0.001) in same-age females.25  
Ganesan et al. defined elevated BP if it was higher than the 90th percentile, 
including both hypertensive and prehypertensive subjects (Table 1).4,53 
Interestingly, Collins et al. have argued that elevated BP, including 
prehypertension, may be detrimental at lower thresholds than the current 
guidelines. These investigators have suggested that statistical definitions should 
be reconsidered and that definitions be based on long-term cardiovascular risk.60 
Hypertension has been associated with increased mortality in children 
hospitalized with ischemic stroke. In a retrospective review, Brush et al. 
determined the prevalence of hypertension in 84 children in the acute phase after 
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an ischemic stroke (Table 1).49 The relative risk of death in the hospital was 1.7 
times higher (95% CI =1.4-2.0; p = 0.05) and the one-year mortality 4.5 times 
higher (95% CI 0.6-34.5; p =0.096) in children with hypertension. Furthermore, 
hypertension (defined by ICD-9 codes for elevated BP or hypertension) was also 
associated with increased mortality (7.4% vs. 2.8%; p = 0.01) in the larger Kids’ 
Inpatient Database; after adjusting for multiple covariates, hypertensive children 
had a 20% increased risk of mortality (odds ratio 1.2, 95% CI 1.1-3.3, p = 0.04).58 
These investigators also analyzed hospitalization rates for TIA in children57 and 
found that hypertension (as defined above) was present in 33/531 (6.2%) cases 
of TIA, and in 8.1% of TIA subjects 15-18 years of age.57   
 
V. Elevated BP and Hemorrhagic Stroke  
Elevated BP has also been identified as a risk factor for intracerebral 
hemorrhage in children as well. The prevalence of hypertension varied from 3.4 
to ten percent in various hemorrhagic stroke series (Table 2).51,54,61-65 
Hypertension was found in 2/30 (6.6%) subjects from six months to 19 years of 
age with non-traumatic cerebral hemorrhage, regardless of whether there was a 
vascular abnormality.51 Of note, hypertension was defined as a BP of 160/95 
across all ages, a BP that is much higher than the BP thresholds that 
characterize hypertension in children.26 This definition would underestimate the 
prevalence of hypertension in children.  
 
VI. Elevated BP and Recurrent Strokes  
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Hypertension has been recently identified as a risk factor for recurrent strokes in 
childhood cancer survivors.66 Data was obtained from the Childhood Cancer 
Survivor Study, a retrospective cohort study; hypertension independently 
predicted recurrent stroke (hazard ratio 1.9; 95% CI 1.0-3.5; p = 0.052). Stroke 
type (ischemic or hemorrhagic) and definition of hypertension were not reported. 
In contrast, hypertension (defined as BP >90th percentile) was not a significant 
predictor of recurrent clinical stroke or reinfarction in either the whole or the 
cryptogenic group in the Great Ormond Street series.67  
 
VII. Stroke and Sickle Cell Disease  
Sickle cell disease is an autosomal recessive disease with a high risk of overt 
ischemic and hemorrhagic cerebrovascular accidents.68 Untreated sickle cell 
disease is the most frequent cause of childhood stroke;69 some children 
present with ‘silent’ infarctions detectable on MRI and associated with cognitive 
difficulties.70  
There is now increasing interest in elevated BP as a risk factor for stroke in 
sickle cell disease. Elevated systolic BP was associated with an increased 
incidence of both overt and silent cerebral infarction.71-72 A history of 
hypertension was also linked to increased risk in hemorrhagic stroke.73  
Although BP has been typically reported to be lower than in the general 
population, children with sickle cell disease were found to have abnormal BP 
patterns.74-76 In a cross-sectional review, 8/48 (16.7%) children with sickle cell 
disease had elevated BP (prehypertension or hypertension).74 Utilizing 24-hour 
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BP monitoring criteria27,28, 18/52 (35%) of patients had previously unrecognized 
hypertension, 9/52 (17%) had pre-hypertension and 29/52 (56%) lacked the 
normal nocturnal dip in BP. In addition, masked hypertension was found to be 
prevalent in the sickle cell population.76 While only 4/38 (10.3%) children with 
sickle cell disease were hypertensive based on clinic BP, 17/38 (43.6%) had 
ambulatory hypertension confirmed by 24-hour BP measurements. Lastly, a large 
national database showed a significant increase in hypertension (defined by 
discharge codes) as an important comorbidity, from 1.5 percent in 1997 to 11.5 
percent in 2006 in children with sickle cell hospitalized with stroke.77  
 
VIII. Stroke and Genetic Disorders  
Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor suppressor 
syndrome characterized by histologically benign tumors of the peripheral and 
central nervous system, as well as the skin. Patients with NF1 have an increased 
risk of cerebrovascular disease. The odds of stroke are significantly increased for 
both adult and pediatric subjects with NF1 compared with the general 
population.78 The risk is higher for hemorrhagic strokes (odds 1.9; p<0.0001), 
although it is also increased for ischemic strokes in children (odds ratio, 3.4; 
p<0.0001). Pediatric patients were more likely to have hypertension. In addition 
to being hypertensive as part of their disease (related to the presence of 
neurofibromin in aortic smooth muscle),79,80 patients with NF1 may have 
secondary peripheral vasculopathy, like renal artery stenosis or renal moyamoya 
predisposing to hypertension. The development of a pheochromocytoma is 
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another risk factor predisposing to hypertension and, in selective cases, to 
stroke.42  
Tuberous Sclerosis Complex (TSC) is an autosomal-dominant neurocutaneous 
disease characterized by widespread hamartomas and benign or rarely malignant 
neoplasms affecting various organs.81,82 Renal involvement is present in more than 
50% of cases, most commonly renal angiomyolipomas or cysts.81,82 About 2% to 
3% of these patients have bilateral polycystic kidney, because of mutation of two 
adjacent genes on chromosome 16, which is diagnosed in infancy or early 
childhood.83 Furthermore, hypertension is a well-known complication of TSC 
mainly caused by renal cyst involvement or angiomyolipomas.82  More rarely, 
hypertension may be secondary to renovascular occlusion or aortic aneurysm.84 
Although a wide variety of central nervous system abnormalities are associated 
with TSC, intracerebral hemorrhage and hemorrhagic stroke are rare.85 In most of 
the reported cases, it is associated with either underlying cerebrovascular 
malformation, like ectasia, aneurysm and arteriovenous malformation or 
hemorrhage into the subependymal giant cell astrocytoma.86-88  
Fabry disease, an inherited disorder caused by deficiency of alpha-galactosidase 
A activity, is associated with high morbidity and mortality related to renal, cardiac, 
and cerebrovascular disease, which are also important outcomes in patients with 
elevated blood pressure.89-91 Among cardiovascular manifestations of Fabry 
disease there is a high prevalence of uncontrolled hypertension, left ventricular 
hypertrophy, rhythm and conduction abnormalities, increased intima media 
thickness, valvular insufficiency, and ischemic heart disease.92,93 Vital organ 
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function progressively declines over time, placing patients with Fabry disease at 
risk of developing renal failure, cardiovascular dysfunction, and stroke.93,94  
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the 
development and progressive enlargement of cysts in the kidneys, and a 
multitude of extra renal manifestations, including the development of intracranial 
aneurysms. Subarachnoid hemorrhage from a ruptured aneurysm is one of the 
most serious complications, which can occur in children as well.95-97  
 
IX. Stroke and Drug Use and Abuse 
Several drugs -both licit and illicit- have been associated with both hypertension 
and stroke. 98-104  Stroke related to over-the-counter cough and cold drugs (such 
as phenylpropanolamine and pseudoephedrine) was associated with acute 
hypertension and/or vasospasm or angiitis.98  Prescription stimulants may be 
associated with adverse cardiovascular events, including stroke and 
hypertension105,106. However, a systematic review did not find an association 
between stimulant use and adverse cardiovascular outcomes in six of seven 
population-based observational studies in children.99  
Cocaine and amphetamines are the illicit drugs more strongly linked to stroke.102 
Hypertension plays an important role in stroke mechanism for both illicit drugs. 
Both ischemic and hemorrhagic stroke are more common in cocaine and 
amphetamine users. However, hemorrhagic strokes are more frequent with 
amphetamine use, up to twice the risk of cocaine (odds ratio 4.95 vs. 2.33).103,104 
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Marijuana, the most commonly used illicit drug in the US, may be also associated 
with acute cerebrovascular events.102,107,108 A recent population-based analysis 
demonstrated that marijuana use was associated with 17% increased risk of 
hospitalization for acute ischemic stroke.108  
 
 
X. Stroke and Sleep Apnea  
Sleep disordered breathing, including, snoring, sleep apnea and nocturnal 
hypoxemia, is a recognized risk factor for adverse cardiovascular outcomes, 
including hypertension and stroke in adults109 and there is some evidence for a 
link to hypertension in children.110  
There are few data on whether there is an association between sleep-disordered 
breathing, hypertension and stroke in children in the general population, in whom 
the prevalence of this breathing disorder is less than 5%. Children with sickle cell 
disease appear to have a higher prevalence (higher than 10%) of sleep-
disordered breathing, and there have been case reports of stroke in children with 
sickle cell disease and obstructive sleep apnea, although whether any link 
involves hypertension remains uncertain.111-113 In addition, there is evidence that 
children with sickle cell disease with a mean overnight oxygen saturation of less 
than 96% are more likely to have a central nervous system event than those with 
mean overnight oxygen saturation higher than 96%.114 Adenotonsillectomy 
appears to reduce stroke risk in sickle cell disease, but it is not known whether 
this is associated with a reduction in BP.115 
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Recently several groups have looked into whether the mechanism linking stroke 
and sleep-disordered breathing might involve an increase in TCD velocities and if 
so, whether the association is with obstructive sleep apnea or with chronic 
oxygen desaturation. TCD velocities were higher than controls in mild obstructive 
sleep apnea in the general pediatric population, but there was no difference in 
systolic or diastolic BP.116 TCD velocities normalized around a year post-
adenotonsillectomy, but BP was not reported and these neurologically normal 
children were not followed up long term for stroke risk.117  
Goldstein et al. tested the association between polysomnography and TCD 
outcomes in a cohort of children 2 -14 years old with sickle cell disease and did 
not find an association with history of snoring, polysomnography and TCD 
velocities.118 Three children had follow-up TCD recordings six weeks, four and 
six months post-adenotonsillectomy; TCD velocities did not significantly decrease 
in any child. Bader-Meunier reported two children with snoring and sickke cell 
disease in whom abnormal velocities (higher than 200 cm/sec) reduced into the 
normal range (lower than 170 cm/sec),119 but there was no evidence that 
adenotonsillectomy reduced TCD velocities in the larger London series.120 None 
of these studies documented BP. There was no evidence of reduction of TCD 
velocities or BP in a six week trial of auto-adjusting continuous positive airways 
pressure (auto-CPAP) in children with SCD,121 but these will be important 
outcomes in the current Phase II trial of six months of auto-CPAP compared with 
standard care.122 
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XI. Hypertension and Cognition and Potential Implications for 
Neurovascular Health 
There is emerging, preliminary evidence that children with hypertension manifest 
cognitive differences when compared to normotensive controls. These 
preliminary studies consist mostly of database and single-center studies that 
focus primarily on differences in neurocognitive test performance and differences 
in cerebrovascular reactivity between hypertensive and normotensive subjects.123  
Using data from participants in NHANES III, investigators evaluated the 
neurocognitive test performance of children aged 6-16 years with elevated 
systolic BP (≥ 90th percentile) to that of participants with normal systolic BP.  
Elevated systolic BP was independently associated with lower Digit Span scores, 
a measure of working memory and attention.124 In a subsequent prospective, 
small, single-center pilot study, investigators showed that children with sustained 
hypertension had worse executive function compared with normotensive 
controls, as measured by a parental rating scale.125 Furthermore, executive 
function scores in the hypertensive group improved after 12 months of 
antihypertensive medication.126 In addition, Adams et al. showed that children 
with hypertension are more likely to be diagnosed with a learning disability, 
suggesting that they are at increased risk for academic difficulties.127 While the 
physiologic basis of the neurocognitive test performance deficits in children with 
hypertension is not known, pediatric hypertension has been associated with 
alterations in cerebrovascular reactivity, the capacity of the cerebral blood 
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vessels to dilate in response to different stimuli, suggesting possible effects of 
hypertension on the cerebral vasculature.15 
Findings of studies in adults raise concern for the neurovascular implications of 
the above cognitive effects of hypertension in youth.  There is evidence that 
hypertension from young adulthood effects subsequent cognitive decline.  In a 
20-year longitudinal study, Elias et al. examined the relationship between 
hypertension and cognitive decline. The investigators found that young 
hypertensive adults (mean age, 34.9 years) were just as susceptible to 
subsequent BP-associated cognitive decline as were older adults.128 Moreover, 
there is evidence that decreased performance on neurocognitive testing is an 
early manifestation of vascular disease that predicts incident stroke.  In the 
Atherosclerosis Risk in Communities Study, middle-aged participants with 
cognitive test scores in the lower quartile had a significantly higher incidence of 
stroke over a median follow-up period of 6.4 years compared with subjects with 
scores in the highest quartile (p = 0.007).129 Taken together, these observations 
underscore the potential impact of early onset hypertension on neurocognitive 
function, subsequent cognitive decline, and incident stroke.   
 
XII. Conclusions and Recommendations 
In this review, we critically assessed whether there is a link between stroke and 
elevated BP in children, and noted many barriers and limitations that have 
delayed recognition of a possible association. Hypertension is under-recognized 
in the general pediatric population and likely in the pediatric stroke population as 
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well. 
Although hypertension has not been strongly identified as a risk factor in 
childhood stroke to date, it is possible that elevated BP plays a role in its 
pathophysiology. We presented preliminary evidence that may link elevated BP 
to the development of ischemic and hemorrhagic stroke in children. Hence, 
elevated BP may be a significant risk factor that, alone or in combination with 
other risk factors, leads to the development of childhood stroke.5,64 
The American Stroke Association 130 has advocated control of hypertension in 
childhood hemorrhagic and ischemic stroke, but specific recommendations are 
lacking.  We recommend that BP be assessed and correctly measured in all 
children with suspected or confirmed acute stroke. Measurement and timing of 
BP assessment should be standardized.  
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Table 1. First Ischemic Stroke and Elevated Blood Pressure in Children and Adolescents <20 years of age 
  
First Author 
(reference) 
Year Study design Population 
 
Definition Prevalence of Elevated BP  
and/or Hypertension 
 
***Kirkham 
(5) 
2000 Retrospective 
Single center 
Not 
specified 
Not specified 8/83 (10%) with “hypertension” 
**Ganesan 
(53) 
2002 Retrospective 
Prospective 
Two centers 
21 days- 
<20 years 
BP >90th percentile 
(includes prehypertension) 
9/22 (41%) had “elevated BP” 
**Ganesan 
(4) 
 
2003 Retrospective 
Prospective 
Single center 
21days- 
<20 years 
BP >90th percentile 
(includes prehypertension) 
104/208 (50%) had “elevated systolic BP” 
78/208 (37.5%) had “elevated diastolic BP”  
***Lo (54) 2009 Retrospective 
Database 
1 month- 
20 years 
ICD-9 codes for 
hypertension 
172/3,156 (5.4%) with “hypertension” 
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*Bigi (55) 2011 Prospective 
Database 
1 month- 
16 years 
BP ≥95th percentile at 
discharge or preadmission 
history of hypertension 
4/128 (5%) with “hypertension”  
or “history of hypertension” 
 
*Brush (49) 2013 Retrospective 
Single center 
1 month- 
18 years 
BP ≥95th percentile  
 
19/84 (22%) had “hypertension” for 3 days 
***Adil (58) 2015 Retrospective 
Database 
1 month- 
18 years 
ICD-9 codes for  
elevated BP and 
hypertension 
156/2,590 (6%) had “elevated BP  
or hypertension” 
***Grelli (59) 2016 Retrospective 
Single center 
1 month- 
18 years 
BP ≥95th percentile  
 
64/98 (65%) with “hypertension” 
 
BP = blood pressure 
*    hypertension assessed according to standard definitions  
**   study included pre-hypertension and hypertension  
***  study did not provide details how hypertension was diagnosed or defined (discharge diagnoses codes are included in this category) 
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Table 2. Non-traumatic Hemorrhagic Stroke and Hypertension in Children and Adolescents <20 years of age 
 
  
First Author 
(reference) 
Year Study design Population Definition Prevalence of Elevated BP 
 
***Livingston (61) 1986 Retrospective 
Single center 
1 month- 
16 years 
Not specified  1/27 (4%) with “hypertension” 
****Awada (51) 1998 Retrospective 
Multicenter 
birth - <10 
years 
10 -19 years 
BP ≥160/95 1/12 (8%) with “hypertension” 
1/18 (6%) with “hypertension” 
***Meyer-Heim 
(62) 
2003 Retrospective 
Single center 
1 month- 
<18 years 
 
Not specified 3/34 (9%) with “hypertension” 
***Fullerton (63) 2007 Retrospective 
Database 
1 month- 
<20 years 
 
Not specified 4/116 (3.4%) with “hypertension” 
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*Lo (64) 2008 Retrospective 
Single center 
birth -17 
years 
BP >90th 
percentile 
38/85 (45%) with “elevated BP”  
at presentation 
3/22 (14%) with “elevated BP”  
at follow-up 
***Lo (54) 2009 Retrospective 
Database 
1 month- 
20 years 
 
ICD-9 codes  
not specified 
124/2,022 (6.1%) with “hypertension” 
***Jordan  (65) 2009 Retrospective 
Single center 
birth -18 
years 
 
Not specified 3/30 (10%) with “hypertension” 
 
BP = blood pressure 
*    hypertension assessed according to standard definitions  
**   study included pre-hypertension and hypertension  
***  study did not provide details how hypertension was diagnosed or defined (discharge diagnoses codes are included in this category) 
**** hypertension defined at much higher levels than current guidelines 
 
 
 
